Cytotoxic bromotyrosine derivatives from a two-sponge association of Jaspis sp. and Poecillastra sp.

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 24, 2008, Pages 6414-6418

  Shinde, Pramod B ^a   Lee, Yoon Mi ^a   Dang, Hung The ^a   Hong, Jongki ^b   Lee, Chong O ^c   Jung, Jee H ^a  

^a Pusan National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Bromotyrosine derivatives; Cytotoxicity; Jaspis sp.; Marine sponge; NMR; Poecillastra sp.

Indexed keywords

ASPARTIC ACID; BETA ALANINE; BISAPRASIN; BISPSAMMAPLIN A; BROMINE DERIVATIVE; BROMOPSAMMAPLIN A; CYCLOBISPSAMMAPLIN A; DOXORUBICIN; PSAMMAPLIN B; PSAMMAPLIN D; PSAMMAPLIN E; PSAMMAPLIN I; PSAMMAPLIN M; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; LIPOPHILICITY; MASS SPECTROMETRY; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; MODELS, CHEMICAL; MOLECULAR CONFORMATION; PORIFERA; TYROSINE;

JASPIS; POECILLASTRA; TETRACTINOMORPHA;

EID: 56249138249     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.10.082     Document Type: Article

References (34)

1. Chang Y.H., Shin D., Na Z., Lee H.S., Kim D.D., Oh K.B., and Shin J. J. Nat. Prod. 71 (2008) 779
2. Ryu G., Choi B.W., Lee B.H., Hwang K.H., Lee U.C., Jeong D.S., and Lee N.H. Tetrahedron 55 (1999) 13171
3. Jung J.H., Sim C.J., and Lee C.O. J. Nat. Prod. 58 (1995) 1722
4. Park Y., Liu Y., Hong J., Lee C.O., Cho H., Kim D.K., Im K.S., and Jung J.H. J. Nat. Prod. 66 (2003) 1495
5. Shinde P.B., Kim M.A., Son B.W., Lee C.O., and Jung J.H. Nat. Prod. Sci. 13 (2007) 365
6. Shinde, P. B.; Park, T.; Hong, J.; Kim, D. K.; Jung, J. H. Pharm. Biol., in press.
7. 2O. The n-BuOH layer was subjected to MPLC to yield 12 fractions (1-12). Compounds 6 and 12 were obtained by purification of fraction 3 by repeated HPLC separation.
8. 13C NMR data, see Table 1.
9. Friebolin, H. Basic One- and Two-Dimensional NMR Spectroscopy; translated by Becconsall, J. K.; Wiley-VCH, 1998, Chapter 10.
10. 3), 35.7 (C-11), 34.3 (C-12), 28.2 (C-7).
11. Pina C.I., Gautschi J.T., Wang G.Y.S., Sanders M.L., Schmitz F.J., France D., Cornell-Kennon S., Sambucetti L.C., Remiszewski S.W., Perez L.B., Bair K.W., and Crews P. J. Nat. Prod. 66 (2003) 1495
12. Jimenz C., and Crews P. Tetrahedron 47 (1991) 2097
13. Quinoa E., and Crews P. Tetrahedron Lett. 28 (1987) 3229
14. Arabshahi L., and Schmi tz F.J. J. Org. Chem. 52 (1987) 3584
15. Rodriguez A.D., Akee R.K., and Scheuer P.J. Tetrahedron Lett. 28 (1987) 4989
16. Pham N.B., Butler M.S., and Quinn R.J. J. Nat. Prod. 63 (2000) 393
17. Tabudravu J.N., Eijsink G.H., Gooday G.W., Jaspars M., Komander M.L., Synstad B., and Aalten D.M.F. Bioorg. Med. Chem. 10 (2002) 1123
18. Shin J., Lee H.S., Seo Y., Rho J.R., Cho K.W., and Paul V.J. Tetrahedron 56 (2000) 9071
19. McDonald L.A., Swersey J.C., Ireland C.M., Carroll A.R., Coll J.C., Bowden B.F., Fairchild C.R., and Cornell L. Tetrahedron 51 (1995) 5237
20. Faulkner D.J. Nat. Prod. Rep. 16 (1999) 155
21. Fernanda D.O.M., Luis D.O.J.H.H., Galetti F.C.S., Olivia D.S.A., Silva C.L., Hajdu E., Peixinho S., and Berlink R.G.S. Planta Med. 72 (2006) 437
22. Nicholas G.M., Newton G.L., Fahey R.C., and Bewley C.A. Org. Lett. 3 (2001) 1543
23. Perry N.B., Blunt J.W., McCombs J.D., and Munro M.H.G. J. Org. Chem. 51 (1986) 5476
24. Costantino V., Fattorusso E., Mangoni A., and Pansini M. J. Nat. Prod. 57 (1994) 1552
25. Reddy A.V., Ravinder K., Narasimhulu M., Sridevi A., Satyanarayana N., Kondapi A.K., and Venkateswarlu Y. Bioorg. Med. Chem. 14 (2006) 4452
26. Ortlepp S., Sjoegren M., Dahlstroem M., Weber H., Ebel R., Edrada R., Thoms C., Schupp P., Bohlin L., and Proksch P. Mar. Biotechnol. 9 (2007) 776
27. Ahn M.Y., Jung J.H., Na Y.J., and Kim H.S. Gynecol. Oncol. 108 (2008) 27
28. Kim D., Lee I.S., Jung J.H., and Yang S.I. Arch. Pharm. Res. 22 (1999) 25
29. Kim D.H., Shin J., and Kwon H.J. Exp. Mol. Med. 39 (2007) 47
30. Jiang Y.H., Ahn E.Y., Ryu S.H., Kim D.K., Park J.S., Yoon H.J., You S., Lee B.J., Lee D.S., and Jung J.H. BMC Cancer 4 (2004) 70
31. Kim D., Lee I.S., Jung J.H., Lee C.O., and Choi S.U. Anticancer Res. 19 (1999) 4085
32. Jiang Y.H., Ryu S.H., Ahn E.Y., You S., Lee B.D., Jung J.H., and Kim D.K. Nat. Prod. Sci. 10 (2004) 277
33. Shim J.S., Lee H.S., and Shin H.J. Cancer Lett. 203 (2004) 163
34. Mora F.D., Jones D.K., Desai P.V., Panty A., Avery M.A., Feller D.R., Smillie T., Zhou Y.D., and Nagle D.G. J. Nat. Prod. 69 (2006) 547